Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

RMJ. 2016; 41(3): 300-303


In vitro activity of tetracyclines against multi-drug resistant Acinetobacter baumannii

Afreenish Hassan, Javaid Usman, Fatima Kaleem, Maria Mushtaq Gill, Ali Khalid, Muhammad Iqbal.




Abstract

Objective: To assess the in vitro sensitivity of multi drug resistant Acinetobacter baumannii (A.baumannii) against four tetracyclines.
Methodology: Routine clinical specimens were received from various wards of a tertiary care hospital from December 2009 to August 2010. A. baumannii was identified by using standard microbiological procedures. Minimum inhibitory concentration (MIC) was performed by using E-strips (AB-Biodisk) of tetracycline, minocycline, doxycyline and tigecycline for each isolate. Results were analyzed by using SPSS version 17.0.
Results: A total of fifty MDR Acinetobacter baumannii were analyzed during the study period. Among the four tetracyclines tested, minocycline was the most effective against MDR A. baumannii. Forty seven (94%) of the isolates were susceptible to minocycline with an MIC90 value 4 ug/mL.
Conclusion: Among tetracyclines, minocycline is an appropriate option against infections caused by MDR A. baumannii. This study will help our clinicians in finding a suitable treatment against such resistant bacteria.

Key words: Acinetobacter baumannii, Minocycline, Minimum inhibitory concentration (MIC)






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.